KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:GBT
Delisted

GLOBAL BLOOD THERAPEUTICS Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$68.49
+0 (+0%)
At Close: Jan 27, 2023
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $68.49 $68.49 Friday, 27th Jan 2023 GBT stock ended at $68.49. During the day the stock fluctuated 0% from a day low at $68.49 to a day high of $68.49.
90 days $68.49 $68.49
52 weeks $21.65 $73.02

Historical GLOBAL BLOOD THERAPEUTICS prices

Date Open High Low Close Volume
Jan 28, 2022 $25.61 $27.46 $25.25 $27.42 1 636 500
Jan 27, 2022 $26.96 $27.54 $25.52 $25.68 1 680 800
Jan 26, 2022 $27.43 $28.23 $26.33 $26.51 1 612 800
Jan 25, 2022 $27.19 $27.95 $26.09 $26.83 2 051 400
Jan 24, 2022 $26.25 $27.82 $25.21 $27.66 2 155 500
Jan 21, 2022 $26.59 $27.13 $26.12 $26.54 1 511 400
Jan 20, 2022 $28.49 $29.13 $26.53 $26.79 1 858 600
Jan 19, 2022 $27.55 $30.23 $27.30 $27.84 1 367 200
Jan 18, 2022 $28.78 $29.19 $27.34 $27.43 1 510 100
Jan 14, 2022 $27.37 $29.13 $27.14 $28.99 1 100 700
Jan 13, 2022 $29.04 $29.04 $27.60 $27.73 1 445 100
Jan 12, 2022 $30.28 $30.46 $29.08 $29.16 1 356 400
Jan 11, 2022 $29.13 $30.25 $28.85 $30.23 1 025 900
Jan 10, 2022 $28.55 $29.26 $27.47 $29.17 910 400
Jan 07, 2022 $28.37 $29.66 $28.00 $28.63 1 023 400
Jan 06, 2022 $27.69 $28.77 $27.07 $28.41 1 261 300
Jan 05, 2022 $29.32 $29.99 $27.63 $27.67 1 265 100
Jan 04, 2022 $29.88 $30.44 $28.85 $29.33 1 476 717
Jan 03, 2022 $29.56 $31.00 $28.81 $30.46 972 415
Dec 31, 2021 $29.92 $30.59 $29.13 $29.27 717 233
Dec 30, 2021 $30.20 $31.10 $29.59 $29.86 824 737
Dec 29, 2021 $30.58 $31.00 $29.96 $30.25 744 072
Dec 28, 2021 $30.80 $31.94 $30.65 $30.79 959 633
Dec 27, 2021 $32.34 $32.34 $30.88 $30.89 1 284 571
Dec 23, 2021 $30.28 $32.90 $30.00 $32.39 1 535 441
Click to get the best stock tips daily for free!

About GLOBAL BLOOD THERAPEUTICS

GLOBAL BLOOD THERAPEUTICS Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, ... GBT Profile

Golden Star

Ticker Date Change Price
DHT Apr 24 2.04% $11.28
MLI Apr 19 9.66% $52.28
LPLA Apr 19 1.42% $262.59
DOOR Apr 18 0.167% $131.39
LNG Apr 17 1.49% $156.81
FCN Apr 16 1.80% $207.62
ELV Apr 16 5.97% $506.97
AKR Apr 05 4.78% $16.53
ITCI Apr 05 7.04% $68.44
VSTS Apr 04 0.425% $18.82
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT